Credit Suisse analyst Scott Deuschle initiates coverage on General Dynamics (NYSE:GD) with a Neutral rating and announces Price Target of $238.
Reported Late Monday, DURECT Corp. Announces 1-For-10 Reverse Stock Split
URECT Corporation (NASDAQ:DRRX), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver diseases, announced that DURECT's board of
